Data supporting this article. حسب Karel Joineau (21799908)

الموضوعات:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). حسب Karel Joineau (21799908)

الموضوعات:

Demographic and clinical data at baseline. حسب Karel Joineau (21799908)

الموضوعات:

Changes in clinical variables. حسب Karel Joineau (21799908)

الموضوعات:

Change of functional connectivity in the SMN after intervention. حسب Karel Joineau (21799908)

الموضوعات:

Connectivity between the left nucleus accumbens and two clusters. حسب Karel Joineau (21799908)

الموضوعات:

Design of the protocol. حسب Karel Joineau (21799908)

الموضوعات:

Schema of the reflexology circuit and the stimulated reflex zones. a. حسب Karel Joineau (21799908)

الموضوعات:

Changes in RVVs during spontaneous circulation and during CPR. حسب Woo Jin Jung (3279570)

Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4^mut infected mice. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Fig 6D. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviates inflammasome activation and pyroptosis in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 also promotes AIM2-inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

Comparison of histological lesion scores of lungs and brains from PRV-WT and PRV-UL4^mut infected piglets. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviated inflammation in PRV-infected mice. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Fig 5D. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 mutation alleviated inflammasome activation and pyroptosis in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 is a promotor of NLRP3 inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

The UL4 null mutation alleviated inflammasome activation in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 is a promotor of NLRP3 inflammasome Activation. حسب Xiaohua Zhang (350570)

الموضوعات: